|Assembly Actions - Lowercase
Senate Actions - UPPERCASE
|Jan 08, 2020||referred to health|
|Jun 14, 2019||referred to rules|
senate Bill S6505
Archive: Last Bill Status - In Senate Committee Health Committee
- In Committee
- On Floor Calendar
- Passed Senate
- Passed Assembly
- Delivered to Governor
- Signed/Vetoed by Governor
S6505 (ACTIVE) - Details
S6505 (ACTIVE) - Sponsor Memo
BILL NUMBER: S6505 SPONSOR: MARTINEZ TITLE OF BILL: An act to amend the public health law, in relation to establishing a cap on the price of prescription insulin PURPOSE OR GENERAL IDEA OF BILL: Enacting policies to reduce the costs for New Yorkers with diabetes to obtain life-saving and life-sustaining insulin SUMMARY OF PROVISIONS: Section 1 amends the public health law by adding a new section 280-d to define the meaning of "prescription insulin drug," capping the total cost a covered person under any health insurance carrier that provides coverage for prescription insulin drugs at an amount of one hundred dollars per thirty day supply of insulin, regardless of the amount or type of insulin needed to fill such covered person's prescription. Section 2 sets the effective date.
S6505 (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 6505 2019-2020 Regular Sessions I N S E N A T E June 14, 2019 ___________ Introduced by Sens. MARTINEZ, GAUGHRAN -- read twice and ordered print- ed, and when printed to be committed to the Committee on Rules AN ACT to amend the public health law, in relation to establishing a cap on the price of prescription insulin THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. The public health law is amended by adding a new section 280-d to read as follows: § 280-D. PRESCRIPTION INSULIN PRICE CAP. 1. FOR PURPOSES OF THIS SECTION, "PRESCRIPTION INSULIN DRUG" SHALL MEAN A PRESCRIPTION DRUG CONTAINING INSULIN TO BE USED IN THE TREATMENT OF DIABETES AND THAT: (A) IS REQUIRED BY ANY APPLICABLE FEDERAL OR STATE LAW TO BE DISPENSED ONLY PURSUANT TO A PRESCRIPTION; OR (B) IS RESTRICTED BY ANY APPLICABLE FEDERAL OR STATE LAW TO USE BY PRACTITIONERS ONLY. 2. ANY HEALTH INSURANCE CARRIER THAT PROVIDES COVERAGE FOR PRESCRIPTION INSULIN DRUGS PURSUANT TO THE TERMS OF A HEALTH INSURANCE POLICY OR HEALTH BENEFITS PLAN SHALL CAP THE TOTAL COST A COVERED PERSON IS REQUIRED TO PAY FOR A COVERED PRESCRIPTION INSULIN DRUG AT AN AMOUNT NOT TO EXCEED ONE HUNDRED DOLLARS PER THIRTY DAY SUPPLY OF INSULIN, REGARDLESS OF THE AMOUNT OR TYPE OF INSULIN NEEDED TO FILL SUCH COVERED PERSON'S PRESCRIPTION. 3. NOTHING IN THIS SECTION SHALL PREVENT A HEALTH INSURANCE CARRIER FROM REDUCING A COVERED PERSON'S COST FOR INSULIN BY AN AMOUNT GREATER THAN THE AMOUNT SPECIFIED IN SUBDIVISION TWO OF THIS SECTION. § 2. This act shall take effect immediately. EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD13030-01-9
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.